Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia.

Hill SK, Schuepbach D, Herbener ES, Keshavan MS, Sweeney JA.

Schizophr Res. 2004 May 1;68(1):49-63.

PMID:
15037339
2.

Early treatment-induced improvement of negative symptoms predicts cognitive functioning in treatment-naive first episode schizophrenia: a 2-year followup.

Schuepbach D, Hill SK, Sanders RD, Hell D, Keshavan MS, Sweeney JA.

Schizophr Bull. 2004;30(4):837-48.

PMID:
15957199
3.

Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression.

Hill SK, Keshavan MS, Thase ME, Sweeney JA.

Am J Psychiatry. 2004 Jun;161(6):996-1003.

PMID:
15169687
4.

1-year follow-up study of cognitive function in first-episode non-affective psychosis.

Rodríguez-Sánchez JM, Pérez-Iglesias R, González-Blanch C, Pelayo-Terán JM, Mata I, Martínez O, Sánchez-Cubillo I, Vázquez-Barquero JL, Crespo-Facorro B.

Schizophr Res. 2008 Sep;104(1-3):165-74. doi: 10.1016/j.schres.2008.05.020. Epub 2008 Jul 16.

PMID:
18635340
5.

Changes over time in frontotemporal activation during a working memory task in patients with schizophrenia.

Wolf RC, Vasic N, Höse A, Spitzer M, Walter H.

Schizophr Res. 2007 Mar;91(1-3):141-50. Epub 2007 Jan 26.

PMID:
17258892
6.

Correlates of cognitive deficits in first episode schizophrenia.

Heydebrand G, Weiser M, Rabinowitz J, Hoff AL, DeLisi LE, Csernansky JG.

Schizophr Res. 2004 May 1;68(1):1-9.

PMID:
15037334
7.

Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.

Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, Pappadopulos E, Willson DF, Alvir JM, Woerner MG, Geisler S, Kane JM, Lieberman JA.

Am J Psychiatry. 2000 Apr;157(4):549-59.

PMID:
10739413
8.

A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia.

Kelly DL, Buchanan RW, Boggs DL, McMahon RP, Dickinson D, Nelson M, Gold JM, Ball MP, Feldman S, Liu F, Conley RR.

J Clin Psychiatry. 2009 Apr;70(4):518-25. Epub 2009 Apr 7.

PMID:
19358788
9.

Course of cognitive functioning during the stabilization phase of schizophrenia.

Klingberg S, Wittorf A, Sickinger S, Buchkremer G, Wiedemann G.

J Psychiatr Res. 2008 Mar;42(4):259-67. Epub 2007 Apr 2.

PMID:
17400252
10.

Stability of set-shifting and planning abilities in patients with schizophrenia.

Tyson PJ, Laws KR, Roberts KH, Mortimer AM.

Psychiatry Res. 2004 Dec 30;129(3):229-39.

PMID:
15661316
11.

Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia.

Lewis DA, Cho RY, Carter CS, Eklund K, Forster S, Kelly MA, Montrose D.

Am J Psychiatry. 2008 Dec;165(12):1585-93. doi: 10.1176/appi.ajp.2008.08030395. Epub 2008 Oct 15. Erratum in: Am J Psychiatry. 2009 Jan;166(1):120.

12.

The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia.

Selva-Vera G, Balanzá-Martínez V, Salazar-Fraile J, Sánchez-Moreno J, Martinez-Aran A, Correa P, Vieta E, Tabarés-Seisdedos R.

BMC Psychiatry. 2010 Jun 15;10:47. doi: 10.1186/1471-244X-10-47.

13.

Oculomotor and neuropsychological effects of antipsychotic treatment for schizophrenia.

Hill SK, Reilly JL, Harris MS, Khine T, Sweeney JA.

Schizophr Bull. 2008 May;34(3):494-506. Epub 2007 Oct 10.

14.

Impairment of verbal memory and learning in antipsychotic-naïve patients with first-episode schizophrenia.

Hill SK, Beers SR, Kmiec JA, Keshavan MS, Sweeney JA.

Schizophr Res. 2004 Jun 1;68(2-3):127-36.

PMID:
15099597
15.

Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.

Tabarés-Seisdedos R, Balanzá-Martínez V, Sánchez-Moreno J, Martinez-Aran A, Salazar-Fraile J, Selva-Vera G, Rubio C, Mata I, Gómez-Beneyto M, Vieta E.

J Affect Disord. 2008 Aug;109(3):286-99. doi: 10.1016/j.jad.2007.12.234. Epub 2008 Mar 4.

PMID:
18289698
16.

A six-factor model of cognition in schizophrenia and related psychotic disorders: relationships with clinical symptoms and functional capacity.

Gladsjo JA, McAdams LA, Palmer BW, Moore DJ, Jeste DV, Heaton RK.

Schizophr Bull. 2004;30(4):739-54.

PMID:
15957196
17.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
18.

Neuropsychological substrates and everyday functioning implications of prospective memory impairment in schizophrenia.

Twamley EW, Woods SP, Zurhellen CH, Vertinski M, Narvaez JM, Mausbach BT, Patterson TL, Jeste DV.

Schizophr Res. 2008 Nov;106(1):42-9. Epub 2007 Dec 4.

19.

Cognitive impairment in schizophrenia: clinical ratings are not a suitable alternative to neuropsychological testing.

Hofer A, Niedermayer B, Kemmler G, Rettenbacher MA, Trebo E, Widschwendter CG, Fleischhacker WW.

Schizophr Res. 2007 May;92(1-3):126-31. Epub 2007 Mar 12.

PMID:
17350807
20.

Did I say that word or did you? Executive dysfunctions in schizophrenic patients affect memory efficiency, but not source attributions.

Peters MJ, Cima MJ, Smeets T, de Vos M, Jelicic M, Merckelbach H.

Cogn Neuropsychiatry. 2007 Sep;12(5):391-411.

PMID:
17690998

Supplemental Content

Support Center